ATE359513T1 - Hochdurchsatzscreening von verbindungen für biologische wirksamkeit - Google Patents

Hochdurchsatzscreening von verbindungen für biologische wirksamkeit

Info

Publication number
ATE359513T1
ATE359513T1 AT01944494T AT01944494T ATE359513T1 AT E359513 T1 ATE359513 T1 AT E359513T1 AT 01944494 T AT01944494 T AT 01944494T AT 01944494 T AT01944494 T AT 01944494T AT E359513 T1 ATE359513 T1 AT E359513T1
Authority
AT
Austria
Prior art keywords
target
compounds
candidate compound
substrate
candidate
Prior art date
Application number
AT01944494T
Other languages
English (en)
Inventor
Jill Elaine Haizlip
Diane Michele Ignar
Channa K Jayawickreme
Holly Kay King
James Arthur Liacos
Kirsten Marian Young
Jason J Ruan
Howard Ray Sauls Jr
Joel Edward Shaffer
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE359513T1 publication Critical patent/ATE359513T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01944494T 2000-06-13 2001-06-13 Hochdurchsatzscreening von verbindungen für biologische wirksamkeit ATE359513T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21126800P 2000-06-13 2000-06-13
US29453101P 2001-05-30 2001-05-30

Publications (1)

Publication Number Publication Date
ATE359513T1 true ATE359513T1 (de) 2007-05-15

Family

ID=26906001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944494T ATE359513T1 (de) 2000-06-13 2001-06-13 Hochdurchsatzscreening von verbindungen für biologische wirksamkeit

Country Status (8)

Country Link
US (1) US20030219825A1 (de)
EP (1) EP1360495B1 (de)
JP (1) JP2004503249A (de)
AT (1) ATE359513T1 (de)
AU (1) AU2001266902A1 (de)
DE (1) DE60127867T2 (de)
ES (1) ES2284655T3 (de)
WO (1) WO2001096597A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050008212A1 (en) * 2003-04-09 2005-01-13 Ewing William R. Spot finding algorithm using image recognition software
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
WO2007100618A2 (en) * 2006-02-23 2007-09-07 Atto Bioscience Novel cell-based phosphodiesterase assays
EP2146210A1 (de) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Verfahren zur Verwendung eines AG-Protein-gekoppelten Rezeptors zur Identifikation von Peptid-YY (PPY)-Sekretagogen sowie Verbindungen zur Behandlung durch PYY modulierter Leiden
CN101949819B (zh) * 2010-09-16 2013-05-01 北京优纳科技有限公司 一种基于图像识别的细胞计数方法
KR20180117529A (ko) 2017-04-19 2018-10-29 주식회사 프로티나 단백질-단백질 상호작용 분석에 의한 약물 반응성 예측 방법
WO2018194406A1 (ko) * 2017-04-19 2018-10-25 주식회사 프로티나 단백질-단백질 상호작용 분석 방법 및 장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
US5670113A (en) * 1991-12-20 1997-09-23 Sibia Neurosciences, Inc. Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same
AU2953295A (en) * 1994-07-01 1996-01-25 W.R. Grace & Co.-Conn. Hepatocyte test kit
EP0817965A1 (de) * 1995-03-31 1998-01-14 Novo Nordisk A/S Verfahren zur identifizierung biologisch aktiver substanzen durch ihre wirkung auf lebenden zellen
US5780258A (en) * 1996-09-04 1998-07-14 Tularik, Inc Drug screens for regulators of the expression of the obese gene
AU760908B2 (en) * 1997-11-27 2003-05-22 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Identification and characterization of interacting molecules by automated interaction mating
US5976813A (en) * 1997-12-12 1999-11-02 Abbott Laboratories Continuous format high throughput screening
CA2344567A1 (en) * 1998-09-18 2000-03-30 Cellomics, Inc. A system for cell-based screening
WO2001094332A1 (en) * 2000-06-02 2001-12-13 Regents Of The University Of California Profiling of protease specificity using combinatorial fluorogenic substrate libraries

Also Published As

Publication number Publication date
AU2001266902A1 (en) 2001-12-24
ES2284655T3 (es) 2007-11-16
WO2001096597A3 (en) 2003-09-12
EP1360495A2 (de) 2003-11-12
JP2004503249A (ja) 2004-02-05
EP1360495B1 (de) 2007-04-11
DE60127867D1 (de) 2007-05-24
US20030219825A1 (en) 2003-11-27
DE60127867T2 (de) 2008-01-17
WO2001096597A2 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
DE60038127D1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
DE69816663D1 (de) Vorrichtung zur bestimmung von analyten in lösungen
DE60115090D1 (de) Verfahren und kit zur erkennung von kinase aktivität
ATE383442T1 (de) Verfahren zur sequenzierung von polynukleotiden
DE60307645D1 (de) Hoch-durchsatz assay zur messung von zellulären antworten mit hilfe von mikroarrays
ATE421697T1 (de) Verfahren zur identifizierung von verbindungen, die transmembran-proteine beeinflussen
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DE60001406D1 (de) Apparat und methode zur präzisen lokalisierung von reaktionsplatten
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
RU2004126254A (ru) Анализ активности киназы actriib
ATE359513T1 (de) Hochdurchsatzscreening von verbindungen für biologische wirksamkeit
ATE503021T1 (de) Verfahren zum nachweis von endoglykosidase aktivität
ATE404692T1 (de) Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen.
ATE343789T1 (de) Biomolekulares kinetik-messverfahren mit hilfe von einem durchfluss-mikroarray
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
PT1040353E (pt) Metodo de despistagem de um analito e estojo
ATE513058T1 (de) Verdrängungsassay zur detektion von nukleinsäureoligomer-hybridisierungsereignissen
DE60015319D1 (de) Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten
PT1384083E (pt) Metodo de ensaio de transcobalamina ii
FR2875242B1 (fr) Nouveaux substrats enzymatiques derives de phenoxazinone et leur utilisation comme revelateur dans la detection de microorganismes a activite peptidase
HUP0400130A2 (en) Scintillation proximity assays for aminoglycoside binding molecules
WO2003098187A3 (en) Assays and kits for detecting the presence of nitriles and/or cyanide
DK1738177T3 (da) Fremgangsmåde til analyse af N-terminale proteinaddukter
DE50011831D1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen
ATE213274T1 (de) Verfahren zur beurteilung der aktivität von arzneistoffen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties